PL1730147T3 - Podstawowe związki 1,4,8-triazaspiro[4.5]dekan-2-onu - Google Patents
Podstawowe związki 1,4,8-triazaspiro[4.5]dekan-2-onuInfo
- Publication number
- PL1730147T3 PL1730147T3 PL05716285T PL05716285T PL1730147T3 PL 1730147 T3 PL1730147 T3 PL 1730147T3 PL 05716285 T PL05716285 T PL 05716285T PL 05716285 T PL05716285 T PL 05716285T PL 1730147 T3 PL1730147 T3 PL 1730147T3
- Authority
- PL
- Poland
- Prior art keywords
- compounds
- triazaspiro
- decan
- treatment
- obesity
- Prior art date
Links
- HFPLVVCVTUVAPK-UHFFFAOYSA-N 1,4,8-triazaspiro[4.5]decan-3-one Chemical class N1C(=O)CNC11CCNCC1 HFPLVVCVTUVAPK-UHFFFAOYSA-N 0.000 title abstract 2
- 208000008589 Obesity Diseases 0.000 title 1
- 235000020824 obesity Nutrition 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Child & Adolescent Psychology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Seasonings (AREA)
- Confectionery (AREA)
- General Preparation And Processing Of Foods (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004014296A DE102004014296A1 (de) | 2004-03-22 | 2004-03-22 | Substituierte 1,4,8-Triazaspiro[4.5]decan-2-on-Verbindingen |
| PCT/EP2005/003029 WO2005095402A1 (de) | 2004-03-22 | 2005-03-22 | Substituierte 1,4,8-triazaspiro [4.5]decan-2-on-verbindungen zur behandlung von fettsucht |
| EP05716285A EP1730147B1 (de) | 2004-03-22 | 2005-03-22 | Substituierte 1,4,8-triazaspiro[4.5 decan-2-on-verbindungen zur behandlung von fettsucht |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1730147T3 true PL1730147T3 (pl) | 2010-07-30 |
Family
ID=34961883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05716285T PL1730147T3 (pl) | 2004-03-22 | 2005-03-22 | Podstawowe związki 1,4,8-triazaspiro[4.5]dekan-2-onu |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7951815B2 (pl) |
| EP (1) | EP1730147B1 (pl) |
| JP (1) | JP2007529565A (pl) |
| AT (1) | ATE457027T1 (pl) |
| CA (1) | CA2560293C (pl) |
| CY (1) | CY1109962T1 (pl) |
| DE (2) | DE102004014296A1 (pl) |
| DK (1) | DK1730147T3 (pl) |
| ES (1) | ES2340502T3 (pl) |
| PL (1) | PL1730147T3 (pl) |
| PT (1) | PT1730147E (pl) |
| SI (1) | SI1730147T1 (pl) |
| WO (1) | WO2005095402A1 (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7977358B2 (en) | 2007-07-26 | 2011-07-12 | Hoffmann-La Roche Inc. | Pyrazol derivatives |
| US9340558B2 (en) | 2007-11-02 | 2016-05-17 | Pain Therapeutics Inc. | Filamin a binding anti-inflammatory and analgesic |
| US8653068B2 (en) * | 2009-10-30 | 2014-02-18 | Pain Therapeutics, Inc. | Filamin A binding anti-inflammatory and analgesic |
| CA2779252C (en) * | 2008-10-31 | 2015-05-05 | Pain Therapeutics, Inc. | Filamin a-binding anti-inflammatory analgesic |
| US8580808B2 (en) * | 2009-10-30 | 2013-11-12 | Pain Therapeutic, Inc. | Filamin A-binding anti-inflammatory analgesic |
| EP2488177B1 (en) * | 2008-10-31 | 2016-10-12 | Pain Therapeutics, Inc. | Filamin a binding anti-inflammatory and analgesic |
| US8580809B2 (en) * | 2009-10-30 | 2013-11-12 | Pain Therapeutics, Inc. | Filamin A-binding anti-inflammatory analgesic |
| EP2872899B1 (en) | 2012-07-13 | 2018-07-11 | Pain Therapeutics, Inc. | Alzheimer's disease assay in a living patient |
| EP2882428B1 (en) | 2012-07-13 | 2019-01-16 | Pain Therapeutics, Inc. | A method of inhibiting tau phosphorylation |
| US10092574B2 (en) | 2012-09-26 | 2018-10-09 | Valorisation-Recherche, Limited Partnership | Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof |
| US9433604B2 (en) | 2013-10-08 | 2016-09-06 | Pain Therapeutics Inc. | Method for inhibiting growth of cancer cells |
| WO2020048826A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 5-substituted 1-oxa-3,9-diazaspiro[5.5]undecan-2-one compounds |
| WO2020048831A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 5-aryl-3,9-diazaspiro[5.5]undecan-2-one compounds |
| AR116020A1 (es) | 2018-09-03 | 2021-03-25 | Bayer Ag | COMPUESTOS DE 3,9-DIAZAESPIRO[5.5]UNDECANO COMO INHIBIDORES DE GGTasa I Y SU USO PARA EL TRATAMIENTO DE ENFERMEDADES HIPERPROLIFERATIVAS |
| WO2020048828A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Pharma Aktiengesellschaft | 5-heteroaryl-3,9-diazaspiro[5.5]undecane compounds |
| WO2020048827A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 1, 3, 9-triazaspiro[5.5] undecan-2-one compounds |
| WO2020048830A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 5-aryl-3,9-diazaspiro[5.5]undecan-2-one compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3725389A (en) * | 1971-07-02 | 1973-04-03 | American Home Prod | Adducts of delta-aminobenzylpenicillin and n-substituted-4-piperidones |
| JP2575446B2 (ja) * | 1988-02-12 | 1997-01-22 | 武田薬品工業株式会社 | トリアザスピロ化合物 |
| SI0921125T1 (en) * | 1997-12-05 | 2002-04-30 | F. Hoffmann-La Roche Ag | 1,3,8-Triazaspiro(4,5)decan-4-on derivatives |
| DE69905798T2 (de) * | 1998-06-12 | 2004-02-12 | F. Hoffmann-La Roche Ag | Di- oder Triazaspiro[4,5]decanderivate |
| WO2000034280A1 (en) * | 1998-12-09 | 2000-06-15 | Banyu Pharmaceutical Co., Ltd. | 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds |
| WO2001096337A1 (en) * | 2000-06-14 | 2001-12-20 | Banyu Pharmaceutical Co.,Ltd | 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds |
| CA2454785C (en) * | 2001-07-23 | 2010-09-07 | Banyu Pharmaceutical Co., Ltd. | 4-oxoimidazolidine-2-spiropiperidine derivatives |
-
2004
- 2004-03-22 DE DE102004014296A patent/DE102004014296A1/de not_active Withdrawn
-
2005
- 2005-03-22 AT AT05716285T patent/ATE457027T1/de active
- 2005-03-22 DK DK05716285.1T patent/DK1730147T3/da active
- 2005-03-22 DE DE502005008971T patent/DE502005008971D1/de not_active Expired - Lifetime
- 2005-03-22 CA CA2560293A patent/CA2560293C/en not_active Expired - Fee Related
- 2005-03-22 PL PL05716285T patent/PL1730147T3/pl unknown
- 2005-03-22 PT PT05716285T patent/PT1730147E/pt unknown
- 2005-03-22 JP JP2007504340A patent/JP2007529565A/ja not_active Ceased
- 2005-03-22 SI SI200530982T patent/SI1730147T1/sl unknown
- 2005-03-22 EP EP05716285A patent/EP1730147B1/de not_active Expired - Lifetime
- 2005-03-22 ES ES05716285T patent/ES2340502T3/es not_active Expired - Lifetime
- 2005-03-22 WO PCT/EP2005/003029 patent/WO2005095402A1/de not_active Ceased
-
2006
- 2006-09-22 US US11/525,057 patent/US7951815B2/en not_active Expired - Fee Related
-
2010
- 2010-04-09 CY CY20101100325T patent/CY1109962T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1730147A1 (de) | 2006-12-13 |
| US20070015784A1 (en) | 2007-01-18 |
| WO2005095402A1 (de) | 2005-10-13 |
| ES2340502T3 (es) | 2010-06-04 |
| JP2007529565A (ja) | 2007-10-25 |
| PT1730147E (pt) | 2010-04-16 |
| CA2560293A1 (en) | 2005-10-13 |
| CY1109962T1 (el) | 2014-09-10 |
| DK1730147T3 (da) | 2010-05-31 |
| US7951815B2 (en) | 2011-05-31 |
| DE502005008971D1 (de) | 2010-03-25 |
| EP1730147B1 (de) | 2010-02-03 |
| SI1730147T1 (sl) | 2010-05-31 |
| WO2005095402A9 (de) | 2009-06-11 |
| ATE457027T1 (de) | 2010-02-15 |
| DE102004014296A1 (de) | 2005-10-06 |
| CA2560293C (en) | 2013-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109962T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας | |
| CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
| TW200508214A (en) | Novel compounds | |
| CY1108794T1 (el) | Σπειροκυκλικα παραγωγα κυκλοεξανιου | |
| PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
| TW200606162A (en) | Pyrazolopyridine derivatives | |
| TW200730525A (en) | Therapeutic agents | |
| TW200738658A (en) | Novel compounds | |
| TW200633978A (en) | 2,3,4,9-tetrahydro-1H-carbazole derivatives as crth2 receptor antagonists | |
| TW200626553A (en) | Novel compounds | |
| TW200639156A (en) | New compounds | |
| TW200745122A (en) | New compounds I | |
| TW200605888A (en) | Novel compounds | |
| PT1869038E (pt) | Compostos de 5,6,7,8-tetra-hidro-imidazo[1,2-a]piridin-2- ilamina substituída e sua utilização para produzir fármacos | |
| TW200626581A (en) | Compounds, compositions containing them, preparation thereof and uses thereof | |
| TW200728300A (en) | Therapeutic agents | |
| MY146802A (en) | Novel drugs for treating respiratory diseases | |
| TW200504051A (en) | Novel acridine derivatives and their use as medicaments | |
| MXPA05013368A (es) | Derivados de indolilo biciclico y metodos para su uso como agentes serotonergicos. | |
| NO20072090L (no) | Forbindelser, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav II | |
| ZA200605653B (en) | Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours | |
| AU2003298203A1 (en) | Medicaments containing substituted 2,5-diaminomethyl-1h-pyrroles | |
| TW200616970A (en) | Compounds, compositions containing them, preparation thereof and uses thereof | |
| TW200621750A (en) | Compounds, compositions containing them, preparation thereof and uses thereof | |
| UA87327C2 (ru) | Производные бензимидазола, композиция, которая их содержит, их получение и применение |